Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Class A common stock, par value $0.0001 per share
-
Shares outstanding
-
1,261,821
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
3,015,414
-
Shares change
-
+813,441
-
Total reported value, excl. options
-
$33,611,838
-
Value change
-
+$9,084,045
-
Number of buys
-
6
-
Number of sells
-
-1
-
Price
-
$11.19
Significant Holders of Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) as of Q2 2024
18 filings reported holding DNQAF - Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share as of Q2 2024.
Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,015,414 shares
.
Largest 10 shareholders include METEORA CAPITAL, LLC (608,172 shares), Calamos Advisors LLC (350,000 shares), GLAZER CAPITAL, LLC (311,044 shares), KIM, LLC (247,252 shares), BERKLEY W R CORP (224,632 shares), Westchester Capital Management, LLC (224,555 shares), Crossingbridge Advisors, LLC (189,544 shares), Centiva Capital, LP (187,764 shares), AQR Arbitrage LLC (162,177 shares), and Karpus Management, Inc. (137,050 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.